Literature DB >> 8344785

Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction.

K Tobal1, L S Sherman, A J Foss, S L Lightman.   

Abstract

PURPOSE: Uveal melanoma is the most common intraocular malignancy in adults and can cause loss of vision in the affected eye and death from metastasis, usually to the liver. The techniques currently used to detect cellular dissemination from the tumor are inadequate, and lack the sensitivity required for the detection of low levels of melanocytes in the peripheral blood of patients. The detection of circulating melanocytes is important as an early indication of the possibility of metastasis.
METHODS: The viability of reverse transcription/polymerase chain reaction amplification of the tyrosinase gene to detect circulating melanocytes was examined as a first sign of dissemination from uveal melanoma.
RESULTS: It was shown that it is possible to detect as few as ten circulating melanocytes in 5 ml of blood. Blood-borne dissemination was also detected in three of six patients with uveal melanoma examined. Two of these patients had clinically confirmed widespread metastases. A positive result was also recorded in one patient in whom there was no other evidence for tumor dissemination. Overt metastatic disease developed in this patient 9 months after blood collection.
CONCLUSIONS: The success of this technique has important implications for the detection of circulating tumor cells from uveal melanoma, as an early indication of dissemination. This may be important when considering the administration of adjuvant therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344785

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

Review 1.  Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma.

Authors:  Daniël P de Bruyn; Aaron B Beasley; Robert M Verdijk; Natasha M van Poppelen; Dion Paridaens; Ronald O B de Keizer; Nicole C Naus; Elin S Gray; Annelies de Klein; Erwin Brosens; Emine Kiliç
Journal:  Biomedicines       Date:  2022-02-21

2.  Uveal melanoma: Ocular and systemic disease.

Authors:  Cristina Miyamoto; Matthew Balazsi; Silvin Bakalian; Bruno F Fernandes; Miguel N Burnier
Journal:  Saudi J Ophthalmol       Date:  2012-04

3.  Tissue-based microarray expression of genes predictive of metastasis in uveal melanoma and differentially expressed in metastatic uveal melanoma.

Authors:  Hakan Demirci; David Reed; Victor M Elner
Journal:  J Ophthalmic Vis Res       Date:  2013-10

Review 4.  Blood Biomarkers of Uveal Melanoma: Current Perspectives.

Authors:  Manuel F Bande Rodríguez; Beatriz Fernandez Marta; Nerea Lago Baameiro; Maria Santiago-Varela; Paula Silva-Rodríguez; María Jose Blanco-Teijeiro; Maria Pardo Perez; Antonio Piñeiro Ces
Journal:  Clin Ophthalmol       Date:  2020-01-20

5.  Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling.

Authors:  Mona Meng Wang; Chuanfei Chen; Myoe Naing Lynn; Carlos R Figueiredo; Wei Jian Tan; Tong Seng Lim; Sarah E Coupland; Anita Sook Yee Chan
Journal:  Front Mol Biosci       Date:  2021-01-06

Review 6.  Do Extracellular RNAs Provide Insight into Uveal Melanoma Biology?

Authors:  Cristina Barbagallo; Chiara Bianca Maria Platania; Filippo Drago; Davide Barbagallo; Cinzia Di Pietro; Michele Purrello; Claudio Bucolo; Marco Ragusa
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.639

Review 7.  Future perspectives of uveal melanoma blood based biomarkers.

Authors:  Aaron B Beasley; Fred K Chen; Timothy W Isaacs; Elin S Gray
Journal:  Br J Cancer       Date:  2022-02-21       Impact factor: 9.075

Review 8.  Liquid Biopsy in Uveal Melanoma: Are We There Yet?

Authors:  Eva Jin; Julia V Burnier
Journal:  Ocul Oncol Pathol       Date:  2020-07-29

9.  The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction.

Authors:  A J Foss; M J Guille; N L Occleston; P G Hykin; J L Hungerford; S Lightman
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

10.  High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma.

Authors:  T J de Vries; D Trancikova; D J Ruiter; G N van Muijen
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.